A Phase 1, Open-Label, Dose Escalation, Safety, and Tolerability Study of INCB054828 in Subjects with Advanced Malignancies

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Phase 1, Open-Label, Dose Escalation, Safety, and Tolerability Study of INCB054828 in Subjects with Advanced Malignancies

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.